SCHEDULE 13D

Company

Skye Bioscience, Inc.

Filed

November 10, 2014

Accession Number

0001557240-14-000654

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →